Legal & General Group Plc (LON:LGEN – Get Free Report) insider John Kingman bought 726 shares of the business’s stock in a transaction on Tuesday, October 1st. The shares were acquired at an average price of GBX 226 ($3.02) per share, with a total value of £1,640.76 ($2,194.70).
Legal & General Group Trading Down 0.4 %
LON LGEN traded down GBX 0.80 ($0.01) during trading hours on Tuesday, reaching GBX 225.50 ($3.02). The company’s stock had a trading volume of 14,204,476 shares, compared to its average volume of 17,023,875. The firm has a fifty day simple moving average of GBX 225.83 and a 200-day simple moving average of GBX 236.78. The company has a debt-to-equity ratio of 722.64, a current ratio of 1.12 and a quick ratio of 0.50. Legal & General Group Plc has a 52 week low of GBX 203.10 ($2.72) and a 52 week high of GBX 259 ($3.46). The stock has a market cap of £13.17 billion, a P/E ratio of 4,510.00, a P/E/G ratio of 2.34 and a beta of 1.31.
Legal & General Group Cuts Dividend
The firm also recently declared a dividend, which was paid on Friday, September 27th. Stockholders of record on Thursday, August 22nd were issued a dividend of GBX 6 ($0.08) per share. The ex-dividend date was Thursday, August 22nd. This represents a dividend yield of 2.77%. Legal & General Group’s dividend payout ratio (DPR) is presently 42,000.00%.
Analysts Set New Price Targets
Get Our Latest Analysis on Legal & General Group
About Legal & General Group
Legal & General Group Plc provides various insurance products and services in the United Kingdom, the United States, and internationally. It operates in Legal & General Retirement Institutional (LGRI), Legal & General Investment Management (LGIM), Legal & General Capital (LGC), and Retail segments.
Recommended Stories
- Five stocks we like better than Legal & General Group
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Why Lennar Stock Could Be the Best Play in the Housing Market
- Business Services Stocks Investing
- 2 Energy Stocks Fueling the AI Datacenter Boom
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Legal & General Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Legal & General Group and related companies with MarketBeat.com's FREE daily email newsletter.